Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Dark Pool Levels


Aldeyra Therapeutics Earlier Announced Receipt Of Orphan Drug Designation From FDA For ADX-2191 To Treat Retinitis Pigmentosa


Benzinga | Aug 4, 2021 08:48AM EDT

Aldeyra Therapeutics Earlier Announced Receipt Of Orphan Drug Designation From FDA For ADX-2191 To Treat Retinitis Pigmentosa






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC